Oncology & Cancer

Multigene testing for all breast cancer patients cost-effective

(HealthDay)—Unselected, multigene testing for all patients with breast cancer would be cost-effective in the United Kingdom and the United States, according to a study published online Oct. 3 in JAMA Oncology.

Health

Understanding where patients live can improve patient health

Family physicians typically don't consider where patients live when assessing their health care needs, despite research that indicates a person's environment can significantly affect their health. Things like access to health ...

page 1 from 23